For: | Jiang SX, Qi B, Yao WJ, Gu CW, Wei XF, Zhao Y, Liu YZ, Zhao BS. Berberine displays antitumor activity in esophageal cancer cells in vitro. World J Gastroenterol 2017; 23(14): 2511-2518 [PMID: 28465635 DOI: 10.3748/wjg.v23.i14.2511] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i14/2511.htm |
Number | Citing Articles |
1 |
Yanhong Yang, Zili Lei, Li Huang, Fei Yang, Na Zhang, Jian Yuan, Kundong Li, Juan Chen, Jufeng Zhang. Antitumor Ability of Berberine Accompanied by Modulation of Gut Microbiome in Sarcoma-180 Tumor-bearing Mice. International Journal of Pharmacology 2018; 14(4): 460 doi: 10.3923/ijp.2018.460.470
|
2 |
Ruo-Gu Xiong, Si-Yu Huang, Si-Xia Wu, Dan-Dan Zhou, Zhi-Jun Yang, Adila Saimaiti, Cai-Ning Zhao, Ao Shang, Yun-Jian Zhang, Ren-You Gan, Hua-Bin Li. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Molecules 2022; 27(14): 4523 doi: 10.3390/molecules27144523
|
3 |
Hua Luo, Chi Teng Vong, Hanbin Chen, Yan Gao, Peng Lyu, Ling Qiu, Mingming Zhao, Qiao Liu, Zehua Cheng, Jian Zou, Peifen Yao, Caifang Gao, Jinchao Wei, Carolina Oi Lam Ung, Shengpeng Wang, Zhangfeng Zhong, Yitao Wang. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chinese Medicine 2019; 14(1) doi: 10.1186/s13020-019-0270-9
|
4 |
Xiao-Hong Guo, Shui-Shan Jiang, Li-Li Zhang, Jun Hu, Dilda Edelbek, Yu-Qi Feng, Zi-Xian Yang, Peng-Chao Hu, Hua Zhong, Guo-Hua Yang, Fang Yang. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway. Oncology Reports 2021; 46(6) doi: 10.3892/or.2021.8204
|
5 |
Naina Rajak, Bentham Science Publisher Kavita, Praveen Kumar, Shikha Singh, Neha Garg. Bioactive Phytochemicals from Himalayas: A Phytotherapeutic Approach. 2023; : 89 doi: 10.2174/9789815123289123010010
|
6 |
Amirhossein Davoodvandi, Sahand Sadeghi, Seyed Mohammad Amin Alavi, Seyedeh Shaghayegh Alavi, Ameneh Jafari, Haroon Khan, Michael Aschner, Hamed Mirzaei, Mehran Sharifi, Zatollah Asemi. The therapeutic effects of berberine for gastrointestinal cancers. Asia-Pacific Journal of Clinical Oncology 2024; 20(2): 152 doi: 10.1111/ajco.13941
|
7 |
Banzeer Ahsan Abbasi, Javed Iqbal, Riaz Ahmad, Sitara Bibi, Tariq Mahmood, Sobia Kanwal, Sheeza Bashir, Farhat Gul, Safia Hameed. Potential phytochemicals in the prevention and treatment of esophagus cancer: A green therapeutic approach. Pharmacological Reports 2019; 71(4): 644 doi: 10.1016/j.pharep.2019.03.001
|
8 |
Diandian Ba, Hongzhe Li, Rongrong Liu, Ping Zhang, Yongmin Tang. Exploratory study on the efficacy of bortezomib combining mitoxantrone or CD22-CAR T therapy targeting CD19-negative relapse after CD19-CAR T cell therapy with a simpler cell-line-based model. Apoptosis 2023; 28(11-12): 1534 doi: 10.1007/s10495-023-01853-1
|
9 |
Qingsong Liu, Jianyuan Tang, Shuanglan Chen, Shuangyuan Hu, Caifei Shen, Juyi Xiang, Nianzhi Chen, Jundong Wang, Xiao Ma, Yi Zhang, Jinhao Zeng. Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa’s cascade underlie its therapeutic effects. Pharmacological Research 2022; 184: 106440 doi: 10.1016/j.phrs.2022.106440
|
10 |
Zhi Chen, Yuzhen Liu, Bo Qi, Chengwei Gu, Xiufeng Wei, Ling Guo, Wenjian Yao, Baosheng Zhao. MicroRNA‑212 facilitates the motility and invasiveness of esophageal squamous carcinoma cells. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10647
|
11 |
Esra Aydemir, Emre Can Tüysüz, Ömer Faruk Bayrak, Didem Tecimel, Ayşen Aslı Hızlı-Deniz, Fikrettin Şahin. Impact of silencing eEF2K expression on the malignant properties of chordoma. Molecular Biology Reports 2023; 50(4): 3011 doi: 10.1007/s11033-023-08257-z
|
12 |
Jin Huang, Wei Feng, Shanshan Li, Huiling Tang, Siru Qin, Wei Li, Yinan Gong, Yuxin Fang, Yangyang Liu, Shenjun Wang, Yi Guo, Zhifang Xu, Qian Shen. Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways. Current Pharmaceutical Design 2021; 27(4): 565 doi: 10.2174/1381612826666200928155728
|
13 |
Liliya Kazantseva, José Becerra, Leonor Santos-Ruiz. Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy. Molecules 2022; 27(15): 5008 doi: 10.3390/molecules27155008
|
14 |
Yuli Fu, Yu Kong, You Wang, Yiwen Cao, Shihua Zhong, Mancai Xu, Ting Lei, Jianhan Huang. Phenolic hydroxyl functionalized hyper-crosslinked polymers and their efficient adsorption. Separation and Purification Technology 2023; 318: 123817 doi: 10.1016/j.seppur.2023.123817
|
15 |
Xuemei Xu, Zhaojingtao Zhu, Siyu Chen, Yanneng Fu, Jinxia Zhang, Yangyang Guo, Zhouyang Xu, Yingying Xi, Xuebao Wang, Faqing Ye, Huijun Chen, Xiaojiao Yang. Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents. Frontiers in Chemistry 2024; 12 doi: 10.3389/fchem.2024.1384301
|
16 |
Hengameh Khosravani, Reza Ataee Disfani, Bahar Farhadi, Mobina Tohidian, Lida Garrosi, Proushat Shirvani, Mohammad Reza Zabihi, Mohammad Akhoondian, Narges Norouzkhani, Ramyar Farzan. Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses-experimental research. Annals of Medicine & Surgery 2024; doi: 10.1097/MS9.0000000000002317
|
17 |
Ganesh C. Jagetia. Anticancer Potential of Natural Isoquinoline Alkaloid Berberine. Journal of Exploratory Research in Pharmacology 2021; 0(000): 000 doi: 10.14218/JERP.2021.00005
|
18 |
Tulika Mitra, Rahul Bhattacharya. Phytochemicals modulate cancer aggressiveness: A review depicting the anticancer efficacy of dietary polyphenols and their combinations. Journal of Cellular Physiology 2020; 235(11): 7696 doi: 10.1002/jcp.29703
|
19 |
Xiang-Yun Lan, Tzu-Ting Chung, Chien-Ling Huang, Yi-Jang Lee, Wan-Chun Li. Traditional Herbal Medicine Mediated Regulations during Head and Neck Carcinogenesis. Biomolecules 2020; 10(9): 1321 doi: 10.3390/biom10091321
|
20 |
Xinghua Gao, Jikai Liu, Daming Fan, Xiaofeng Li, Zhiqing Fang, Keqiang Yan, Yidong Fan. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Oncology Reports 2021; 47(2) doi: 10.3892/or.2021.8244
|
21 |
Xihui Chen, Shiwen Wang, Li Zhang, Shuying Yuan, Tong Xu, Feng Zhu, Yanmei Zhang, Lijun Jia. Celastrol Inhibited Human Esophageal Cancer by Activating DR5-Dependent Extrinsic and Noxa/Bim-Dependent Intrinsic Apoptosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.873166
|
22 |
Yun Jin, Jiawei Zhang, Yunfeng Pan, Wangzhen Shen. Berberine Suppressed the Progression of Human Glioma Cells by Inhibiting the TGF-β1/SMAD2/3 Signaling Pathway. Integrative Cancer Therapies 2022; 21 doi: 10.1177/15347354221130303
|
23 |
Siwang Hu, Ruochi Zhao, Yahui Liu, Junzheng Chen, Zhijian Zheng, Shuangshuang Wang. Preventive and Therapeutic Roles of Berberine in Gastrointestinal Cancers. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/6831520
|
24 |
Catarina Melim, Mariana Magalhães, Ana Cláudia Santos, Elisa Julião Campos, Célia Cabral. Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade. Expert Opinion on Drug Delivery 2022; 19(2): 179 doi: 10.1080/17425247.2022.2041599
|
25 |
Yijing Ren, Cheng Lv, Jing Zhang, Beibei Zhang, Bei Yue, Xiaoping Luo, Zhilun Yu, Hao Wang, Junyu Ren, Zhengtao Wang, Wei Dou. Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK/c-Jun signaling pathway. Molecular and Cellular Biochemistry 2021; 476(12): 4387 doi: 10.1007/s11010-021-04247-6
|
26 |
Wen-Jian Liu, Yuan Zhao, Xu Chen, Man-Li Miao, Ren-Quan Zhang. Epigenetic modifications in esophageal cancer: An evolving biomarker. Frontiers in Genetics 2023; 13 doi: 10.3389/fgene.2022.1087479
|
27 |
Jing Su, Ran Zhang, Yumei Lian, Zul Kamal, Zhongyao Cheng, Yujiao Qiu, Mingfeng Qiu. Preparation and Characterization of Erythrocyte Membrane-Camouflaged Berberine Hydrochloride-Loaded Gelatin Nanoparticles. Pharmaceutics 2019; 11(2): 93 doi: 10.3390/pharmaceutics11020093
|
28 |
Yi Feng, Ning-xi Li, Huan-li Yin, Tian-yu Chen, Qian Yang, Min Wu. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs. Molecular Pharmaceutics 2019; 16(1): 422 doi: 10.1021/acs.molpharmaceut.8b01073
|
29 |
Fang Cao, Han-Ling Zhang, Cui Guo, Xue-Liang Xu, Qiang Yuan. Targeting oxidative stress with natural products: A novel strategy for esophageal cancer therapy. World Journal of Gastrointestinal Oncology 2024; 16(2): 287-299 doi: 10.4251/wjgo.v16.i2.287
Abstract(346) |
Core Tip(285) |
Full Article(HTML)(1072)
|
Full Article with Cover (PDF)-3140K(95)
|
Full Article (Word)-1667K(21)
|
Audio-692K(23)
|
Peer-Review Report-216K(35)
|
Answering Reviewers-48K(44)
|
Full Article (PDF)-2872K(75)
|
Full Article (XML)-167K(57)
|
Times Cited (0)
|
Total Visits (2938)
|
Open
|
30 |
Saleh A. Almatroodi, Mohammed A. Alsahli, Arshad Husain Rahmani. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways. Molecules 2022; 27(18): 5889 doi: 10.3390/molecules27185889
|
31 |
Maura Calvani, Angela Subbiani, Gennaro Bruno, Claudio Favre. Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/7534693
|
32 |
Yingying Yang, Junru Shen, Peiyuan Deng, Ping Chen.
Mechanism investigation of Forsythoside A against esophageal squamous cell carcinoma
in vitro
and
in vivo
. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2380023
|
33 |
Shanshan Nie, Yuhang Zhao, Xinjian Qiu, Wenbo Wang, Ye Yao, Min Yi, Dongsheng Wang. Metabolomic Study on Nude Mice Models of Gastric Cancer Treated with Modified Si Jun Zi Tang via HILIC UHPLC-Q-TOF/MS Analysis. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/3817879
|
34 |
Qing Fang, Yuyin Zhu, Qilai Wang, Meijun Song, Guosheng Gao, Zhiming Zhou. Suppression of cyclooxygenase 2 increases chemosensitivity to sesamin through the Akt‑PI3K signaling pathway in lung cancer cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3939
|
35 |
Abdur Rauf, Tareq Abu-Izneid, Anees Ahmed Khalil, Muhammad Imran, Zafar Ali Shah, Talha Bin Emran, Saikat Mitra, Zidan Khan, Fahad A. Alhumaydhi, Abdullah S. M. Aljohani, Ishaq Khan, Md. Mominur Rahman, Philippe Jeandet, Tanweer Aslam Gondal. Berberine as a Potential Anticancer Agent: A Comprehensive Review. Molecules 2021; 26(23): 7368 doi: 10.3390/molecules26237368
|
36 |
AmirReza Hesari, Faezeh Ghasemi, Arrigo F. G. Cicero, Mohammad Mohajeri, Omid Rezaei, Seyed Mohammad Gheibi Hayat, Amirhossein Sahebkar. Berberine: A potential adjunct for the treatment of gastrointestinal cancers?. Journal of Cellular Biochemistry 2018; 119(12): 9655 doi: 10.1002/jcb.27392
|
37 |
Jie Ying, Miaomiao Zhang, Xiaoyan Qiu, Yu Lu. The potential of herb medicines in the treatment of esophageal cancer. Biomedicine & Pharmacotherapy 2018; 103: 381 doi: 10.1016/j.biopha.2018.04.088
|
38 |
Qihong Nie, Wei Wei Peng, Yuli Wang, Liting Zhong, Xuebing Zhang, Ling Zeng. β-catenin correlates with the progression of colon cancers and berberine inhibits the proliferation of colon cancer cells by regulating the β-catenin signaling pathway. Gene 2022; 818: 146207 doi: 10.1016/j.gene.2022.146207
|
39 |
Taís Vidal Palma, Nathiele Botari Bianchin, Juliana Sorraila de Oliveira, Charles Elias Assmann, Mona das Neves Oliveira, Maria Rosa Chitolina Schetinger, Vera Maria Morsch, Henning Ulrich, Micheli Mainardi Pillat, Cinthia Melazzo de Andrade. Berberine increases the expression of cytokines and proteins linked to apoptosis in human melanoma cells. Molecular Biology Reports 2022; 49(3): 2037 doi: 10.1007/s11033-021-07022-4
|